The Pulmonary Manifestations of Generalised Scleroderma
نویسنده
چکیده
Two aspects of generalised scleroderma have received much attention in recent years. Firstly, the widespread and sclerotic nature of the disease process has been embodied in the term “progressive systemic sclerosis,” proposed by Goetz’ in 1945, and since adopted by other authors. Secondly, connective tissue alterations are now regarded as an integral part of this entity which answers all the criteria of a grave collagen disturbance. The purpose of this paper is to re-examine the known and possible pulmonary manifestations of systemic sclerosis, as the disease will here be termed, with reference to these newer concepts. Pleural and vascular involvement in allied collagen disorders (e.g. disseminated lupus erythematosus) are well established. The possibility of similar lesions in systemic sclerosis is therefore raised. Hypertension in the pulmonary circuit, an entity which has recently received wide attention, is known to result from both pulmonary fibrosis and pulmonary arteritis. Systemic sclerosis is an established cause of the former, and full evidence of pulmonary vascular involvement will be presented. The relationship between systemic sclerosis and pulmonary hypertension will accordingly be examined and amplified. The pulmonary manifestations of systemic sclerosis to be discussed in this paper are:
منابع مشابه
بررسی تغییرات اسپیرومتری و علایم بالینی ریوی در بیماران اسکلرودرمی تحت درمان با سیکلوفسفامید وریدی
Background & Aims: Scleroderma is a systemic condition with various manifestations in different organs. Among these organs, the lungs are affected very frequently, and the involvement is progressive and significant. Various medications have been suggested and tested in patients with scleroderma and lung involvement, but their efficacy and safety profile differ and enforce a difficult final...
متن کاملThe Relationship between Serum Pro‐Brain Natriuretic Peptide (Pro‐BNP) Levels and Pulmonary Arterial Hypertension (PAH) in Patients with Limited Scleroderma
Introduction: Pulmonary arterial hypertension (PAH) is a late progressive sclerodermarelated complication, which can lead to right heart failure and cor pulmonale. Given that cardiac catheterization is a diagnostic method of choice for PAH, and considering the high risks of this method, the purpose of this study was to evaluate the relationship between serum Pro‐Brain natriuretic peptide (Pro‐B...
متن کاملA brief overview of the pathogenesis of scleroderma (systemic sclerosis).
Although definitive answers are not yet forthcoming, understanding the mechanisms of fibrosis in scleroderma might improve the relative therapeutic vacuum now surrounding not only generalised scleroderma (systemic sclerosis (SSc)) but also the fibrosis of keloid formation, cirrhosis of the liver, pulmonary fibrosis, and atherosclerosis as well. Discussion here will include immune, vascular, and...
متن کاملThe Role of EDD (Exercise Capacity, Dyspnea, and Diffusing Capacity of Lungs for Carbon Monoxide) Index in Pulmonary Fibrosis Secondary to Scleroderma
Introduction: Pulmonary involvement secondary to Systemic Sclerosis (SSc) is the major cause of morbidity and mortality in SSc patients. We designed this study to determine the correlation of important lung function parameters with lung High Resolution CT (HRCT) scan findings. Materials and Methods: Thirty–two consecutive diffuse SSc patients with pulmonary fibrosis were enrolled in this cross...
متن کاملThe Assessment of Health-Related Quality of Life in Scleroderma-Interstitial Lung Disease
Introduction: Pulmonary involvement is the most common cause of mortality and disability in patients with systemic sclerosis and it significantly affects the quality of life in these patients. Therefore, early diagnosis and treatment of pulmonary involvement seems necessary in patients with SSc. In this study, we aimed to assess the health-related quality of life (HRQoL) in patients with Sclero...
متن کامل